Industry committee  Has your opinion on CCSVI changed?

Questions Passed as Orders for Returns   and their practice of medicine guidelines, (ii) and if off-label use falls under provincial jurisdiction, why did the federal government intervene regarding the new procedure for chronic cerebrospinal venous insufficiency (CCSVI); (c) what are the regulatory requirements for the special access

Pan-Canadian Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI) Act  moved for leave to introduce Bill C-410, An Act to establish a Pan-Canadian Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI). Mr. Speaker, my bill aims to establish a pan-Canadian strategy for chronic cerebrospinal venous insufficiency, or CCSVI. The bill calls

Questions on the Order Paper  With respect to clinical trials for chronic cerebrospinal venous insufficiency (CCSVI): (a) what was the deadline for receiving applications for clinical trials for CCSVI and has the application process closed; (b) how many applications were received, and, for each application

National Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI) Act  moved for leave to introduce Bill C-280, An Act to establish a National Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI). Mr. Speaker, my bill aims to establish a national strategy for chronic cerebrospinal venous insufficiency, CCSVI. The bill calls

Health committee   published reports on CCSVI intervention, much of the support for endovascular interventions in CCSVI currently comes from anecdotal patient self-reports posted on web sites, blogs, and chat rooms. Prospective randomized control trials will be necessary to fully understand the impact

Petitions  Mr. Speaker, I am pleased to present this petition on CCSVI. The government claims that most of what I am asking for in Bill C-280 is already underway, which is absolutely not the case. For example, follow-up care remains a problem today and has not been adequately assessed

National Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI) Act  Mr. Speaker, I would like to quote again from the leading experts in North America in this field who say: We strongly believe that an adaptive phase II/III trial will allow for a fast and effective research path to get the answers we all need regarding CCSVI. To do otherwise

Health committee  CCSVI is a medical procedure. My group in my branch is responsible for approving different products. If a product was to be used and manufacturers wanted to come forward and advertise their product for use in a procedure such as CCSVI, they would have to come through us. To date

Health committee  Well, if we look at Tysabri, we fast-tracked a drug knowing that it caused a fatal brain infection. I see a real dichotomy between the way CCSVI has been treated and the way Tysabri has been treated. I have spoken to the researcher who created the molecule. If we go back

Petitions  Mr. Speaker, the second petition is regarding CCSVI. The petitioners call for the Minister of Health to consult experts actively engaged in the diagnosis and treatment of CCSVI to undertake a phase III clinical trial on an urgent basis at multiple centres across Canada

Petitions  Mr. Speaker, I am pleased to present this petition regarding CCSVI. The petitioners understand that the government will fund a trial but question the non-announcement announcement. Who was the research team? Why phase I-II when three FDA phase II studies are under way

Petitions  Mr. Speaker, I am pleased to present this petition regarding CCSVI. Thirty thousand treatments have been undertaken in 60 countries, while Canada has failed to begin clinical trials. The U.S. is already undertaking three FDA approved clinical trials. The U.K. encourages robust

Petitions  Mr. Speaker, I am pleased to present this petition regarding CCSVI. Former deputy surgeon general and director general of the Laboratory Centre for Disease Control, Dr. Michael Shannon, writes: Having lived through the restructuring of the Canadian Blood System in the late 90

National Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI) Act  The House resumed from February 15 consideration of the motion that Bill C-280, An Act to establish a National Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI), be read the second time and referred to a committee.